# File: merged.pdf.pdf
- File ID: `merged.pdf`
- Pages: 5

---


## Page 1

U3: Packing plan adherence has been better compared to the
previous month

### Figure Data (Page 1)
```plaintext
[TYPE]: CHART
[SUMMARY]: The chart illustrates the production performance in million tablets, comparing the original plan, completed production, operational constraints, and revisions for contingency.
[DATA]: 
Category,Value
Original plan,281
Completed,199
Operational constraints,84
Revised for contingency,-2
```


### Figure Data (Page 1)
```plaintext
[TYPE]: CHART
[SUMMARY]: The chart shows production plan adherence percentages for February and March 2018.
[DATA]: 
Month,Adherence Percentage
Feb '18,66%
Mar '18,70%
```

Production performance (Mn Tabs)
Demand coverage (MTO + backlog)
Production plan adherence
Capacity utilization : 72% (199 Mn)

### Figure Data (Page 1)
```plaintext
[TYPE]: CHART
[SUMMARY]: The chart shows the percentage values for two months, February and March 2018, with additional data on demand and dispatch for March.
[DATA]: 
Month,Percentage
Feb'18,19%
Mar'18,21%

Additional Data:
- March Demand: 936 Mn
- March Dispatch: 193 Mn
```

(Capacity = 277 Mn Tablets)
100%
100%
199
50%
50%
281
70%
66%
84
21%
19%
-2
0%
0%
contingency
Operational
Completed
Original plan
constraints
Revised for
Mar'18
Feb'18
Feb' 18
Mar' 18
March Demand : 936 Mn
Plan - 281 Mn, Actual - 199 Mn
(Within plan - 197 Mn)
March Dispatch: 193 Mn

### Figure Data (Page 1)
```plaintext
[TYPE]: CHART
[SUMMARY]: The image is a bar chart comparing the packing performance for bottles and blisters in March 2018, showing capacity utilization, original plans, completions, operational constraints, and revisions.
[DATA]: 
Category,Original Plan,Completed,Operational Constraints,Revised for Contingency
Bottle,155,128,27,-32
Blister,24,21,3,
```

Mar' 18 packing performance (Mn Tabs)
Packing plan adherence
Blister
Bottle

### Figure Data (Page 1)
```plaintext
[TYPE]: CHART
[SUMMARY]: The bar chart compares the percentage of two packaging types, Bottle and Blister, for February and March 2018.
[DATA]: 
Month, Bottle, Blister
Feb'18, 68%, 82%
Mar'18, 83%, 88%
```

Blister
Bottle
Capacity utilization : 87% (160 Mn)
Capacity utilization : 72% (21Mn)
(Capacity = 183 Mn Tablets)
(Capacity = 29 Mn Tablets)
100%
128
21
155
24
50%
88%
83%
82%
68%
3
-32
27
Operational
Completed
Original plan
constraints
for contingency
Operational
Original plan
Completed
constraints
Revised
0%
Feb'18
Mar'18
Sprint
Responsive Integrated Transformative

## Page 2


### Figure Data (Page 2)
[TYPE]: IMAGE  
[SUMMARY]: This is an image of a medication label for Adrenaline (Epinephrine) Injection. It specifies the concentration as 1:10,000 and the dosage as 1mg in 10ml. The label includes instructions for use, storage conditions, and manufacturer details.  
[DATA]: N/A

printed on White base colour.
Purple - Pantone 256C to be
MARTINDALE PHARMA
THIRD PARTY SUPPLY ARTWORK
ORACLE Finished pack code: 66300
10ml
Description: LBL ADRENALINE 1:10,000 10ML PFS
Market: UK
Adrenaline (Epinephrine)
Supplier: Agila
Development artwork number: D02853
Injection 1:10,000
Date: 06/05/14 By: AC
Version number: 01
1mg in 10ml
Date of previous revision: 01/05/14 (D02853-A)
to
EAN Barcode (if applicable): N/A
For IV, IO or ET tube use
Template/style number: As supplied
2
10ml
8
6
3
5
4
9
7
Colours:
PMS Black C
Use once and discard. Protect from light.
PMS 256 C
Store below 25°C. Do not use if discoloured.
PMS Matt white C
POM
Aurum Pharmaceuticals Ltd
PMS
for overlapping.
6mm mini. gap
PL12064/0006
D02853
Min Point size (legal text): as supplied
Code no: KR/DRUGS/KTK/28/280/95
1025814
Martindale Pharma Artwork Dept
To confirm that all artwork checks have been completed
prior to circulation
Name:
Signature:
Date:
Comments:
Martindale Pharma Regulatory Affairs
Reject X
Accept
Name:
Signature:
100mm MEASUREMENT VERIFICATION BAR
Date:
Comments:
Quality
Reject X
Accept
Name:
Signature:
Date:
Comments:
2853 -A
Software/platform: Creative Suite CC: Illustrator 17.1.0 / OSX 10.9.2
Linked graphics
2953
ARTWORK DETAIL LABEL
Fonts: Myriad Pro (embedded)

| Product | Adrenaline (Epinephrine) Injection - 1:10,000 | Col3 | Col4 | Col5 | Col6 |
| --- | --- | --- | --- | --- | --- |
| Buyer/Country | MARTINDALE PHARMA / UK | Component | Syringe Label |  |  |
| Dimension | 70 60 mm |  |  | Pack | -- |
| New Item Code | 1025814 | Old Item Code | 1016983 |  |  |
| Colour Shades | Black PANTONE 256 C | White | Transparent (Clear) | No. of Colours | 3 |

File name: D02853-01
Component specifics:
Braille
Non printed area
Grand Fromage Creative Limited
Amherst House, 22 London Road
Riverhead, Sevenoaks, Kent, TN13 2BT, UK

| Change Control No. | PC-ATSG/2014/267 Record No.: 64229 | Artwork Version | 1.0 |
| --- | --- | --- | --- |
| Design/Style | Self adhesive labels In Roll-form with Rounded Corners |  |  |
| Substrate | Transparent biaxially oriented poly propylene labels of 46 GSM/62 GSM Release paper / | 16-22 GSM | Adhesive/varnihsed. |
| Special Instructions | Printing clarity to be clear & sharp. |  |  |
| Autocartonator Requirements | NA |  |  |
| Bar | Items | Carton | Label |
| code and 2D Code details for reference | Barcode No. | 7502209853058 | Not Applicable |
|  | 2D Code No. | Not Applicable | 2029 |

t: 01732 456 187
e: alan@grand-fromage.co.uk www.grand-fromage.co.uk
Caution to the printer: Before processing, please ensure that the ARTWORK received for printing is exactly in line with APPROVED ARTWORK
provided to you. In case of any FONTS/DESIGN are Mis-matching with the APPROVED ARTWORK, please inform PDC for further action. DO NOT
MAKE ANY CHANGE TO THE ARTWORK WITHOUT WRITTEN INSTRUCTIONS FROM PDC.
F-10-R0/PDC-001

## Page 3


### Figure Data (Page 3)
```plaintext
[TYPE]: FLOWCHART
[SUMMARY]: This flowchart outlines the batch packing process for hydrocortisone sodium succinate for injection. It details the steps from vial labeling to final packaging and weighing.
[DATA]: 
flowchart TD
    A[Start] --> B[Vial labeling]
    B --> C[Place 1 vial + 1 WFI in a tray]
    C --> D[1 filled tray (1 vial + 1 WFI) in a carton]
    D --> E[Coding of batch details on carton]
    E --> F[Weigh the carton]
    F --> G[270 cartons in a shipper (15L X 6W X3H)]
    G --> H[BOPP taping, Shipper labeling & weighing]
    D --> I[Strapping]
```

Agila Specialties Pvt. Ltd.
BATCH PACKING RECORD-II -A
A Mylan Company
DPP
Sterile Products Division
Sterile Products Division, Bangalore
Bangalore, India
GENERIC NAME : HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION USP
Page 3 of 5
[500MG][SOLHIDROL][1 Vial+1 WFI][SOLARA S A de CV,MEXICO]
BATCH SIZE:
BPR REF NO: 3001262/V10
Note: In Process Frequency: Production - every 1 hr. approximately
Quality assurance - every 2 hrs. approximately
Vials
THEORETICAL YIELD (T) :
PACKING YEILD : NLT 89.50%
YIELD LIMIT: NLT 90%
Process flow chart:
Coding of
batch details on
vial label labels
270 cartons in a
Weigh the
Coding of
1 filled tray
Place 1 vial+ 1
shipper
Vial
batch details on
carton
(1 vial +1 WFI)
WFI in a tray
(15L X 6W X3H)
labeling
carton
in a carton
BOPP taping,
Shipper labeling
Strapping.
& weighing
SLS Qty.: NA
Remarks:
Mit/10/14
Checked by
Prepared by
Production
Quality Assurance

## Page 4

MD10-01-01 INITIN
NITIN LIFESCIENCES LTD. UNIT-III, PAONTA SAHIB
BATCH MANUFACTURING RECORD

| Product Name: MEDIA FILL | Generic Name: NA | OF |
| --- | --- | --- |
| Batch No.: MF10D011801 | Document No.: BMR/DI/028/03 | Effective Date : 17/02/2017 |


| Col1 | Mfg. | Date: Not | Applicable | Col5 | Col6 | Col7 | Col8 |
| --- | --- | --- | --- | --- | --- | --- | --- |
|  | Vial |  |  | Batch | Size |  |  |
|  | Size | Minimum | SCDM Qty. | Washing. machine | Maximum | SCDM Qty. | Washing. machine |
|  | 5 | 6000 Vial | 18.0L | *650 | 10000 Vial | 30.0L | *650 |
|  | 10 | 6000Vial | 36.0L | *650 | 10000 Vial | 60.0L | *650 + |
|  | 20 30 | 6000Vial 6000Vial | 72.0L 108.0L | *650 *650 | 10000 Vial 10000 Vial | 120.0L 180.0L | *650 *650 |
|  |  |  |  |  |  |  |  |

Exp. Date: Not Applicable
Avg. Fill Vol: For 5ml Vial 3.0 ml
For 10ml Vial 6.0 ml
For 20ml Vial 12.0ml
For 30ml Vial 18.0ml
* Vial quantity mentioned applicable only when washing machine validation planned with media fill.
ength : 3%w/v
\
Version No. : 03
Supersedes : 02

| Mfg. Lic. No. | Not Applicable |
| --- | --- |
| Shelf Life: | Not Applicable |


| MBF Ref. No: | Not | BMR Issued By | 03/01/2018 |
| --- | --- | --- | --- |
|  | Applicable | BMR Checked By | 1 03/01/2018 |
| Date of Commencement | 04/01/2018 | Date of Completion | 07/01/2018 |
| PREPARED BY | CHECKED | BY | APPROVED BY |
| Production Executive | Production Manager / Head | QA Executive | QA Manager / Head |
| Blued | A | d | Thatam |
| 16/02/2017 | 16/02/2017 | 16/02/2017 | 16/02/2017 |
|  |  | REASON FOR REVISION |  |
| VERSION No. | SUPERSEDES | CHANGE INCORPORATED | EFFECTIVE DATE |
| V3 | V2 | Company name changed (Ref.No: PC-SPD/2013/250) Tunnel conveyor speed revised as per SOP No.: PDN/002 BET sample collection included as per SOP QAD/062 (Ref.No: PC-SPD/2013/169) Instruction included to ensure working condition of CCTV during line clearance as per SOP No.: QAD/006 CCP points included for vial washing line clearance (Ref. No: PC-SPD/2013/254) Visual inspection table revised SOP. No.: PDN/011 Provision for recording names/ signatures of all Personnel involved in product handling activity included as per SOP. No.: QAD/022 (Ref.No: PC-SPD/2014/076 & SPD-CAPA-2014-011) Total visual Inspection rejection Reconciliation procedure incorporated. (Ref.No: PC-SPD/2014/314) Sample collection time incorporated as per SOP. No.:QAD/062 Provision provided for stage wise rejection and facilitated to document the destruction details as per SOP. No.: PDN/049 (Ref.No: PC-CAPA-2014-567 & Ref.No: PC-SPD/2014/330) | 11 SEP 2014 |
| Part 1 contains : | Part 1-A: Product description, Storage condition, Dispensing, Washing and Sterilization. | Part1-B: Manufacturing, Filtration, Filling and Visual inspection. | Addendum (if any) |
| Page No. | 01 to 17 | 18 to 58 |  |

Document Reviewed By:
Quality Assurance Sign/Date: /29/201/2018
Production Sign/Date:
MASTER COPY
Page 1 of 28

## Page 5

Agila Specialties Pvt.Ltd.
BATCH MANUFACTURING RECORD (Part 1)
A Mylan Company
VIAL
Sterile Products Division
Sterile Products Division Bilekahalli, Bangalore.
Bangalore,India
Page 1 of 56
GENERIC NAME : Tobramycin Injection USP [40mg/mL] [2mL]
BATCH SIZE. : 100 L
BATCH NO. :
BMR REF NO.: 2003470/V3
DATED : 04/05/2012
MFR No: MFR/00008817/R02
BMR No. :
DATED : 18/07/2012
BOM No: BOM/00008817/R03
MARKET/CUSTOMER : Canada (Agila)
PRODUCT CODE : 2003470
EXPIRY DATE :
MANUFACTURING DATE :
PROCESS VALIDATION
NA
02
03
01
SHELF LIFE : 24 months
Verified by (QA)
Checked by (PDN)
Excluding / including the month of
Signature & Date:
Signature & Date :
manufacturing
DATE OF COMPLETION
DATE OF COMMENCEMENT
ISSUED BY QA :
ISSUANCE DATE:
DESCRIPTION OF PRODUCT: Clear colorless liquid free from visible particles.
LABEL CLAIM: Each mL contains Tobramycin sulfate equivalent to Tobramycin USP 40 mg.
STORAGE: Store at 15°C to 30°C [USP controlled room temperature]
Documents Attached: The complete Batch History Record (BHR), i.e.; [Batch Manufacturing Record (BMR)
Part 1 + Batch Packing Record (BPR) Part 2] is enclosed in an envelope along with respective Annexures.
This batch manufacturing records consists of 58 pages which is approved & authorized by following personnel.
AUTHORISED BY:
APPROVED BY:
CHECKED BY:
QUALITY ASSURANCE
PRODUCTION
QUALITY ASSURANCE
SA 11/09/14
dishing
11/09/14
11/09/14
NAME: Anand babu.
NAME: C. Kanappa
NAME:
KSG. shyam,
SIGN AND DATE
SIGN AND DATE
SIGN AND DATE
"MASTER DOCUMENT" IF IN GREEN SHEETS.
"CONTROLLED DOCUMENT" IF IN YELLOW SHEETS.
"UNCONTROLLED" IF IN WHITE SHEETS.
Checked by:
Prepared by :
is
T10/09/14
10/09/14
Production
Quality Assurance